 |  |
BioHorizons Camlog combines two families of implant solutions with proven track records in the demanding markets of America and Europe.
Implant dentists choosing the right brand or system to meet their patient’s needs have their work cut out for them. With over 150 dental implant companies out there offering a bewildering assortment of products, it can be a challenge narrowing down the field.
For those who just want to focus on the clinical task at hand, Henry Schein is offering a one-stop alternative with BioHorizons Camlog.
When BioHorizons and Camlog joined forces under the umbrella of Henry Schein's Global Oral Reconstruction Group (GORG) in 2017, the merger brought together two world-class implant companies that originated from both sides of the Atlantic Ocean.
BioHorizons Camlog offers a consolidated portfolio of products from implant systems to restorative solutions; intelligent workflows to regenerative biomaterials. This evidence-based portfolio benefits from Henry Schein’s established local support network, including their comprehensive customer service team.
“We now have the confidence to say to the Australian clinician: “We have everything you need in one place””, says Kellie Paull, the National Surgical Business Manager at Henry Schein Australia.
“That’s because we have combined two amazing brands – each with a true global reach –with an extensive range of biomaterials.”
Star-spangled innovations
Born in the USA, BioHorizons was founded through research conducted at the University of Alabama in 1994 by Carl E. Misch, DDS, Martha Bidez, PhD and Todd Strong, COO of BioHorizons. Steve Boggan joined in 1995 and later became the CEO.
Firmly entrenched in scientific research, BioHorizons produced several breakthrough proprietary technologies, including: the BioHorizons 3inOne abutment in 1997, Laser-Lok microchannels in 2007 for implants and later the Laser-Lok surface technology was added to abutments to create a biologic seal that protects and maintains crestal bone in the aesthetic zone. Over the last few years the company launched Tapered Pro with unique design elements to provide predictable solutions for immediate and Full Arch treatments. The product design was based on more than 10 years of tapered implant success.
BioHorizons is also a trailblazer in the biological field of dentistry. In 2000, BioHorizons brought to market the AlloDerm™ Regenerative Tissue Matrix (RTM), a widely accepted and researched acellular dermal matrix for dental soft tissue applications.
In 2004, the company added the popular MinerOss® to an already stellar line-up. A mixture of allograft mineralized cortical and cancellous chips, MinerOss® addresses a wide range of dental bone grafting applications.
Today, BioHorizons is distributed globally in 90 markets including Asia, North America, South America, Africa, Australia, and Europe.
European flair
Founded in Germany, Camlog is one of Europe’s leading suppliers of dental implant systems, restorative components, regenerative and digital solutions.
The Camlog brand was first introduced in 1999 as a range of products – including the Camlog Cylinder-Line and Screw-Cylinder-Line – with Altatec GmbH as the legal manufacturer.
Interestingly, Altatec was the new moniker given to EBERLE Medizintechnik in 1995. The latter is the original name of the German dental implant firm founded in 1988 by renowned dentist and oral surgeon Dr Axel Kirsch.
After several products bearing the Camlog name gained market prominence, it made perfect sense to use it as an overarching customer-facing identifier.
Standout Camlog products over the years include: Camlogs Screw Line Implant in 2002; Conelog Screw Line Implant in 2011; DEDICAM CAD/CAM prosthetic solutions and Camlog iSy Implants in 2013; and in 2019, Conelog Progress Line implant system designed to address immediate and Full Arch implant treatments was introduced.
The products are manufactured in state of the arts technology at its Wimsheim location.
Intercontinental spread
Camlog and BioHorizons presented their newly formed partnership for the first time at the IDS 2019 in Cologne, Germany.
Behind the scenes, the two companies have been “strategically evolving” under Henry Schein's Global Oral Reconstruction Group (GORG) since 2017.
Henry Schein is a FORTUNE 500 Company that thrives on providing dental practitioners solutions to help them work more efficiently and render quality care more effectively. The formation of GORG is no exception, Kellie attests.
“The optimum user experience lies at the heart of what we do,” she says.
“Whether it’s a type of connection, material, thread design, leading to treatment protocol a particular patient need or situation, we’ve got you covered with a single brand.”
On the marketing front, a fresh logo and modern collaterals greet customers in a brand new website (www.biohorizonscamlog.online) showcasing all the products under the joint brand. Products include implant lines such as: Tapered PTG, Tapered Pro, Tapered 3.0, Tapered Short, CONELOG®, and iSy®.
“Whether you are a surgeon, prosthodontist or dental technician, our product portfolio can be tailored to meet your specific preference,” Kellie explains.
“For overseas-educated Aussie dentists, you may either be more familiar with an American- or European-style implant system. What’s special about BioHorizons Camlog is that it provides a versatile intercontinental menu of choices.”
“We offer evidence-based solutions for different concepts and requirements to cater to as wide a customer base as possible.”
Meeting of minds
The real intersection of the brands, however, is taking place at the R&D level. The holy grail of any merger is the ability to harness the brains behind the success of each entity. Both BioHorizons and Camlog have their R&D teams to thank for a steady supply of ingenious product output over the years.
With the two innovation minds now sharing the same passions in serving patients’ need, Kellie urges customers to stay tuned to “some exciting developments in coming years”.
As it stands, Aussie dentists can already look forward to BioHorizon Camlog’s wide selection of implant systems and established products for hard and soft tissue regeneration from a single source. Henry Schein’s dedicated surgical team and massive support network is on standby to provide the necessary guidance.
“An implant practitioner typically keeps a few brands in their armamentarium, and not least because patient needs vary – it’s important that we are able to offer choice to our customers,” Kellie says.
“That said, with BioHorizons Camlog, we are providing customers with more than just another option on the market but also a go-to portfolio of dental implant solutions.
“BioHorizons is already one of the most popular brands in Australia. BioHorizons Camlog is simply taking the portfolio to a whole new level.”
Implant dentists choosing the right brand or system to meet their patient’s needs have their work cut out for them. With over 150 dental implant companies out there offering a bewildering assortment of products, it can be a challenge narrowing down the field.
For those who just want to focus on the clinical task at hand, Henry Schein is offering a one-stop alternative with BioHorizons Camlog.
When BioHorizons and Camlog joined forces under the umbrella of Henry Schein's Global Oral Reconstruction Group (GORG) in 2017, the merger brought together two world-class implant companies that originated from both sides of the Atlantic Ocean.
BioHorizons Camlog offers a consolidated portfolio of products from implant systems to restorative solutions; intelligent workflows to regenerative biomaterials. This evidence-based portfolio benefits from Henry Schein’s established local support network, including their comprehensive customer service team.
“We now have the confidence to say to the Australian clinician: “We have everything you need in one place””, says Kellie Paull, the National Surgical Business Manager at Henry Schein Australia.
“That’s because we have combined two amazing brands – each with a true global reach –with an extensive range of biomaterials.”
Star-spangled innovations
Born in the USA, BioHorizons was founded through research conducted at the University of Alabama in 1994 by Carl E. Misch, DDS, Martha Bidez, PhD and Todd Strong, COO of BioHorizons. Steve Boggan joined in 1995 and later became the CEO.
Firmly entrenched in scientific research, BioHorizons produced several breakthrough proprietary technologies, including: the BioHorizons 3inOne abutment in 1997, Laser-Lok microchannels in 2007 for implants and later the Laser-Lok surface technology was added to abutments to create a biologic seal that protects and maintains crestal bone in the aesthetic zone. Over the last few years the company launched Tapered Pro with unique design elements to provide predictable solutions for immediate and Full Arch treatments. The product design was based on more than 10 years of tapered implant success.
BioHorizons is also a trailblazer in the biological field of dentistry. In 2000, BioHorizons brought to market the AlloDerm™ Regenerative Tissue Matrix (RTM), a widely accepted and researched acellular dermal matrix for dental soft tissue applications.
In 2004, the company added the popular MinerOss® to an already stellar line-up. A mixture of allograft mineralized cortical and cancellous chips, MinerOss® addresses a wide range of dental bone grafting applications.
Today, BioHorizons is distributed globally in 90 markets including Asia, North America, South America, Africa, Australia, and Europe.
European flair
Founded in Germany, Camlog is one of Europe’s leading suppliers of dental implant systems, restorative components, regenerative and digital solutions.
The Camlog brand was first introduced in 1999 as a range of products – including the Camlog Cylinder-Line and Screw-Cylinder-Line – with Altatec GmbH as the legal manufacturer.
Interestingly, Altatec was the new moniker given to EBERLE Medizintechnik in 1995. The latter is the original name of the German dental implant firm founded in 1988 by renowned dentist and oral surgeon Dr Axel Kirsch.
After several products bearing the Camlog name gained market prominence, it made perfect sense to use it as an overarching customer-facing identifier.
Standout Camlog products over the years include: Camlogs Screw Line Implant in 2002; Conelog Screw Line Implant in 2011; DEDICAM CAD/CAM prosthetic solutions and Camlog iSy Implants in 2013; and in 2019, Conelog Progress Line implant system designed to address immediate and Full Arch implant treatments was introduced.
The products are manufactured in state of the arts technology at its Wimsheim location.
Intercontinental spread
Camlog and BioHorizons presented their newly formed partnership for the first time at the IDS 2019 in Cologne, Germany.
Behind the scenes, the two companies have been “strategically evolving” under Henry Schein's Global Oral Reconstruction Group (GORG) since 2017.
Henry Schein is a FORTUNE 500 Company that thrives on providing dental practitioners solutions to help them work more efficiently and render quality care more effectively. The formation of GORG is no exception, Kellie attests.
“The optimum user experience lies at the heart of what we do,” she says.
“Whether it’s a type of connection, material, thread design, leading to treatment protocol a particular patient need or situation, we’ve got you covered with a single brand.”
On the marketing front, a fresh logo and modern collaterals greet customers in a brand new website (www.biohorizonscamlog.online) showcasing all the products under the joint brand. Products include implant lines such as: Tapered PTG, Tapered Pro, Tapered 3.0, Tapered Short, CONELOG®, and iSy®.
“Whether you are a surgeon, prosthodontist or dental technician, our product portfolio can be tailored to meet your specific preference,” Kellie explains.
“For overseas-educated Aussie dentists, you may either be more familiar with an American- or European-style implant system. What’s special about BioHorizons Camlog is that it provides a versatile intercontinental menu of choices.”
“We offer evidence-based solutions for different concepts and requirements to cater to as wide a customer base as possible.”
Meeting of minds
The real intersection of the brands, however, is taking place at the R&D level. The holy grail of any merger is the ability to harness the brains behind the success of each entity. Both BioHorizons and Camlog have their R&D teams to thank for a steady supply of ingenious product output over the years.
With the two innovation minds now sharing the same passions in serving patients’ need, Kellie urges customers to stay tuned to “some exciting developments in coming years”.
As it stands, Aussie dentists can already look forward to BioHorizon Camlog’s wide selection of implant systems and established products for hard and soft tissue regeneration from a single source. Henry Schein’s dedicated surgical team and massive support network is on standby to provide the necessary guidance.
“An implant practitioner typically keeps a few brands in their armamentarium, and not least because patient needs vary – it’s important that we are able to offer choice to our customers,” Kellie says.
“That said, with BioHorizons Camlog, we are providing customers with more than just another option on the market but also a go-to portfolio of dental implant solutions.
“BioHorizons is already one of the most popular brands in Australia. BioHorizons Camlog is simply taking the portfolio to a whole new level.”
RSS Feed
